✦ LIBER ✦

Constitutional NF1 mutations in neurofibromatosis 1 patients with malignant peripheral nerve sheath tumors

✍ Scribed by Lan Kluwe; Reinhard E. Friedrich; Matthias Peiper; Jan Friedman; Victor-F. Mautner

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 32 KB
Volume: 22
Category: Article
ISSN: 1059-7794
DOI: 10.1002/humu.9193

No coin nor oath required. For personal study only.

✦ Synopsis

Neurofibromatosis type 1 (NF1) patients have 10% of lifetime risk for developing malignant peripheral nerve sheath tumors (MPNST), one of the most aggressive cancers. We examined the spectrum of constitutional NF1 mutations among 24 NF1 patients with MPNST. We found mutations in 18 patients: four megabase deletions involving the NF1 gene, 13 truncating mutations, and only one missense mutation. One deletion included both exonic and intronic sequences. No typical splicing mutation was found. Five of these mutations were novel: c.3686delA, c.197_204+9del17, c.3044T>C (p.Leu1015Pro), c.2497delT, and c.6020_6027dup. The proportion of megabase deletions of the NF1 gene found in patients with MPNST (17% = 4/24) was higher than that in a group of unselected NF1 patients (5.4% = 27/500).

📜 SIMILAR VOLUMES

Malignant peripheral nerve sheath tumors

Malignant peripheral nerve sheath tumors in neurofibromatosis 1

✍ King, Allison A. ;Debaun, Michael R. ;Riccardi, Vincent M. ;Gutmann, David H. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Germline and somatic NF1 gene mutation s

Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs)

✍ M. Upadhyaya; Lan Kluwe; G. Spurlock; Bisma Monem; E. Majounie; K. Mantripragada 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 1 views

## Communicated by Riccardo Fodde About 10% of neurofibromatosis type 1 (NF1) patients develop malignant peripheral nerve sheath tumors (MPNSTs) and represent considerable patient morbidity and mortality. Elucidation of the genetic mechanisms by which inherited and acquired NF1 disease gene variant

Pathology of tumors of the peripheral ne

Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis

✍ Woodruff, James M. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 3 views

The two main peripheral nerve sheath tumors found in patients with neurofibromatosis, type 1 (NF1), are neurofibroma, a benign tumor, and malignant peripheral nerve sheath tumor (MPNST). The tumors are related in that most MPNSTs are thought to arise by malignant transformation of neurofibromas. Suc

NF1 mutations in neurofibromatosis 1 pat

NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas

✍ Lan Kluwe; Reinhard E. Friedrich; Bruce Korf; Raimund Fahsold; Victor-F. Mautner 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 1 views

Neurofibromatosis 1 (NF1) is an autosomal dominant disorder caused by genetic alterations of the NF1 gene on 17q11.2. About 30% of NF1 patients develop plexiform neurofibromas (PNFs), which often cause severe clinical deficits. To determine whether there is a certain genotype underlying PNFs or subt

The heterogeneous nature of germline mut

The heterogeneous nature of germline mutations in NF1 patients with malignant peripheral serve sheath tumours (MPNSTs)

✍ Meena Upadhyaya; Gill Spurlock; Elisa Majounie; Sian Griffiths; Natalie Forreste 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

Malignant peripheral nerve sheath tumours (MPNSTs) are a major cause of mortality in patients with neurofibromatosis 1 (NF1). We have analysed lymphocyte DNA samples from 30 NF1 patients with MPNSTs to determine their underlying constitutional NF1 gene mutations. Mutations were detected in 27/30 (90

Microarray-based copy number analysis of

Microarray-based copy number analysis of neurofibromatosis type-1 (NF1)-associated malignant peripheral nerve sheath tumors reveals a role for Rho–GTPase pathway genes in NF1 tumorigenesis

✍ Meena Upadhyaya; Gill Spurlock; Laura Thomas; Nick S. T. Thomas; Mark Richards; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 479 KB 👁 1 views

Neurofibromatosis type-1 (NF1) is associated with the growth of benign and malignant tumors. Approximately 15% of NF1 patients develop malignant peripheral nerve sheath tumors (MPNSTs), underlining the need to identify specific diagnostic/prognostic biomarkers associated with MPNST development. The